Timothy Springer

Timothy “Tim” A. Springer, Ph.D. is an American immunologist based in Boston, Massachusetts.

Springer founded LeukoSite in 1993, which he took public in 1998 and sold to Millennium Pharmaceuticals a year later in a deal worth $635 million.¹⁾

In February 2009, Springer invested in Selecta Biosciences.²⁾

Springer was a founding investor of Moderna in 2010, when he put about $5 million into the company. In a May 2020 interview with Forbes, Springer said that he and his co-investors “had the idea very early on that it could be used for pandemic readiness,” adding “That’s why we invested in doing human trials with different influenza types, the types that are not normally seen in epidemics but could emerge and start a new pandemic. We were aware of this kind of scenario all along.”

He co-founded Scholar Rock and Morphic Therapeutic.

In May 2017, Springer donated $10 million to establish the Institute for Protein Innovation (IPI).³⁾

Following the declaration of the COVID-19 pandemic, Springer became a billionaire due to his founding investment in Moderna.

• Wikipedia